These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2645507)

  • 1. [Optimal dosage of acetylsalicylic acid. I: Use in primary and secondary prevention of myocardial infarct and following aortocoronary bypass operation].
    Zichner R; Weihrauch TR
    Med Klin (Munich); 1989 Jan; 84(1):43-51. PubMed ID: 2645507
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary disease: benefits of aspirin. What dose for which disease?].
    Michel PL
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):204-10. PubMed ID: 8024235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin with bypass surgery--from taboo to new standard of care.
    Topol EJ
    N Engl J Med; 2002 Oct; 347(17):1359-60. PubMed ID: 12397195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risk predictors and secondary prevention after PTCA and bypass operations].
    Gulba DC; Waigand J; Osterziel KJ; Dietz R
    Internist (Berl); 1995 Sep; 36(9):891-901. PubMed ID: 7591614
    [No Abstract]   [Full Text] [Related]  

  • 5. [Can patients without coronary heart disease prevent a heart infarct with 30 or 50 mg acetylsalicylic acid?].
    Schreiber M; Sechtem U
    Dtsch Med Wochenschr; 2003 Dec; 128(50):2668. PubMed ID: 14673749
    [No Abstract]   [Full Text] [Related]  

  • 6. [Low-dose ASA and infarct prophylaxis. Acetylsalicylic acid (ASA): low doses with high efficiency].
    Internist (Berl); 1995 Jan; 36(1 Suppl Low-dose-a):1-4. PubMed ID: 9431355
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time.
    Smith PK; Carrier M; Chen JC; Haverich A; Levy JH; Menasché P; Shernan SK; Van de Werf F; Adams PX; Todaro TG; Verrier E
    Ann Thorac Surg; 2006 Sep; 82(3):781-8; discussion 788-9. PubMed ID: 16928483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prevention after coronary artery bypass grafting--what do we know?
    Herlitz J
    Scand Cardiovasc J; 2004 May; 38(2):69-74. PubMed ID: 15204230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acetylsalicylic acid after myocardial infarct].
    Sinzinger H; Kritz H
    Wien Klin Wochenschr; 1997; 109 Suppl 2():25-8. PubMed ID: 9340919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimizing therapeutic success in aortocoronary bypass operations].
    Weber M; Theisen K; Jahrmärker H
    Fortschr Med; 1983 Nov; 101(44):2044-50. PubMed ID: 6606606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case of exterior acute infarct treated with aortocoronary bypass and plication of the left ventricle].
    Perna A; Borzoni G; Calamai G; Venturini
    Arch Chir Torac Cardiovasc; 1975; 32(3-4):231-2. PubMed ID: 1084729
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of reinfarction with 100 mg or 30 mg aspirin daily?].
    Schrör K
    Z Kardiol; 1995 Jun; 84(6):496-8. PubMed ID: 7653091
    [No Abstract]   [Full Text] [Related]  

  • 13. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting.
    Bybee KA; Powell BD; Valeti U; Rosales AG; Kopecky SL; Mullany C; Wright RS
    Circulation; 2005 Aug; 112(9 Suppl):I286-92. PubMed ID: 16159833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of myocardial infarct developing 1 year after aortocoronary shunting].
    Kurashvili LR
    Vrach Delo; 1989 Dec; (12):15-6. PubMed ID: 2629265
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aortocoronary bypass surgery in impending myocardial infarct].
    Vermeulen FE; Ernst JM; Deseins L; de Geest R; Knaepen PJ; Plokker HW
    Ned Tijdschr Geneeskd; 1986 Aug; 130(34):1517-21. PubMed ID: 3489895
    [No Abstract]   [Full Text] [Related]  

  • 16. [Arrhythmias in the rehabilitation period after myocardial revascularization surgery by aortocoronary bypass. Efficacy of anti-arrhythmia therapy with propafenone].
    Bianchi G; Manfredonia A; Lepori G; Locatelli A; Di Salvo F
    Minerva Cardioangiol; 1986 Jun; 34(6):437-42. PubMed ID: 3489908
    [No Abstract]   [Full Text] [Related]  

  • 17. [Have indications for aortocoronary bypass operation changed?].
    Turina M
    Internist (Berl); 1987 Nov; 28(11):747-50. PubMed ID: 3323111
    [No Abstract]   [Full Text] [Related]  

  • 18. [No benefit in the addition of dipyridamole to, nor of anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1993 Dec; 137(51):2669. PubMed ID: 8278004
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.
    Weiss ES; Chang DD; Joyce DL; Nwakanma LU; Yuh DD
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):503-11, 511.e1-3. PubMed ID: 18329460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
    Carrier M; Ménasché P; Levy JH; Newman MF; Taylor KM; Haverich A; Chen JC; Shernan SK; Van de Werf F; van der Laan M; Todaro TG; Adams PX; Verrier ED
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.